Thomas Hoehler

2.4k citations
25 papers · 1.8k · 1 hit paper · h-index 14

Impact in

  • Oncology top 5%
    • Cancer Immunotherapy and Biomarkers
    • Pancreatic and Hepatic Oncology Research
    • Colorectal Cancer Treatments and Studies
    • Gastric Cancer Management and Outcomes

Papers in

Thomas Hoehler

24 papers receiving 1.8k citations

Thomas Hoehler's Hit Papers

Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial 2018 · 1.1k citations
1.1k0+2+5Years since publication2505007501000

Peers

Thomas Hoehler
Comparison fields: 5 of 67
  • Oncology 603
  • Pulmonary and Respiratory Medicine 398
  • Environmental Chemistry 33
  • Immunology 47
  • Epidemiology 57
Replace Lori Koch with:
Lori Koch United States
Martin H. Brownstein United States
Masayuki Kawasaki Japan
Mario Budroni Italy
Hedviga Kerner Israel
Kathryn M. McLaren United Kingdom
David Castenson United States
Tsu‐Yi Chuang United States
Christophe Fermé France
Shigeki Tomita Japan
Thomas Hoehler relative to Lori Koch United States Lori Koch's profile →
Citations per field
00.5×5×10×16.5×
Lori Koch · 1×
Citations per year

Countries citing papers authored by Thomas Hoehler

Since Specialization
Citations

This map shows the geographic impact of Thomas Hoehler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Hoehler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Hoehler more than expected).

Fields of papers citing papers by Thomas Hoehler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Hoehler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Hoehler. The network helps show where Thomas Hoehler may publish in the future.

Co-authors

The 25 scholars most cited alongside Thomas Hoehler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Thomas Hoehler Line = papers co-authored together Thomas Hoehler links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial
Hit paper breakdown →
20181060
2 2000205
3 2001135
4 199172
5 200760
6 200946
7 201741
8 200838
9 201836
10 200935
11 200426
12 200524
13 200318
14 201314
15 201312
16 20178
17 20143
18 20032
19 20042
20 20152

About Thomas Hoehler

Thomas Hoehler is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Hematology, Environmental Chemistry and Hepatology, having authored 25 papers that have together received 1.8k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (7 papers), Pancreatic and Hepatic Oncology Research (4 papers), Colorectal Cancer Treatments and Studies (3 papers), Hepatitis B Virus Studies (2 papers), Erythropoietin and Anemia Treatment (1 paper), Helicobacter pylori-related gastroenterology studies (1 paper), Liver Diseases and Immunity (1 paper) and Psoriasis: Treatment and Pathogenesis (1 paper). The work is most often cited by research in Oncology (603 citations), Pulmonary and Respiratory Medicine (398 citations), Environmental Chemistry (33 citations), Immunology (47 citations) and Epidemiology (57 citations). Thomas Hoehler has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Peter R. Galle, Elisabeth Märker‐Hermann, Esther Reuss, Wiebke Kaluza, Rudolf E. Schopf, H. Hänel, BEATRICE B. ABRAMS, Markus Menges, Markus Hermann Moehler and Stephan Kanzler. Their work appears in journals such as Annals of Oncology, Journal of Hepatology, European Journal of Cancer, Thrombosis and Haemostasis and The Lancet.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact